Petros Pharmaceuticals, Inc. (PTPI) Financials

PTPI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 38.9 million 31.9 million
2023-06-30 28.7 million 15.8 million
2023-03-31 30.6 million 15.1 million
2022-12-31 32.4 million 15.7 million

PTPI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.7 million 30840
2023-06-30 -572070 43316
2023-03-31 -748363 130336
2022-12-31 -1.6 million 228845

PTPI Net Income

No data available :(

PTPI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 18.0 million - 300153
2023-06-30 7.4 million - 183328
2023-03-31 8.3 million - 223575
2022-12-31 9.4 million - 262678

PTPI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.1 million
2023-06-30 2.1 million
2023-03-31 2.1 million
2022-12-31 2.1 million

PTPI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 389093 2.0 million -
2023-06-30 - 866575 2.2 million -
2023-03-31 - 319093 2.1 million -
2022-12-31 - 177762 2.9 million -

PTPI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.7 million 408475
2023-06-30 2.0 million 513857
2023-03-31 2.5 million 550742
2022-12-31 798101 881332

PTPI

Price: $0.70

52 week price:
0.63
9.54

Earnings Per Share: -6.21 USD

P/E Ratio: -0.19

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 7800

Market Capitalization: 2.0 million

Links: